Edition:
United States

BioLife Solutions Inc (BLFS.OQ)

BLFS.OQ on NASDAQ Stock Exchange Capital Market

5.85USD
14 Dec 2017
Change (% chg)

$0.21 (+3.72%)
Prev Close
$5.64
Open
$5.65
Day's High
$5.87
Day's Low
$5.60
Volume
23,349
Avg. Vol
37,964
52-wk High
$7.53
52-wk Low
$1.52

Latest Key Developments (Source: Significant Developments)

Biolife Solutions Executes Supply Agreement With Iovance Biotherapeutics
Wednesday, 13 Dec 2017 06:30am EST 

Dec 13 (Reuters) - Biolife Solutions Inc ::BIOLIFE SOLUTIONS EXECUTES SUPPLY AGREEMENT WITH IOVANCE BIOTHERAPEUTICS.BIOLIFE SOLUTIONS - EXECUTED AGREEMENT TO SUPPLY CRYOSTOR CELL FREEZE MEDIA AND HYPOTHERMOSOL STORAGE AND SHIPPING MEDIA TO IOVANCE BIOTHERAPEUTICS.  Full Article

BioLife Solutions posts Q3 loss per share $0.03
Thursday, 9 Nov 2017 04:05pm EST 

Nov 9 (Reuters) - BioLife Solutions Inc :Biolife Solutions announces third quarter 2017 financial results.Q3 loss per share $0.03.Biolife Solutions Inc - ‍gross margin for Q3 of 2017 was 63 pct compared with 57 pct in Q3 of 2016​.Biolife Solutions Inc - ‍2017 revenue is expected to range between $10.8 million to $11 million​.Biolife Solutions Inc - ‍2017 gross margin is expected to be between 60 pct and 62 pct​.Biolife Solutions Inc - qtrly ‍revenue $2.96 million versus $2.1 million.  Full Article

Biolife Solutions Q2 loss per share $0.06
Thursday, 10 Aug 2017 04:05pm EDT 

Aug 10 (Reuters) - Biolife Solutions Inc :Biolife Solutions announces second quarter 2017 financial results.Sees FY 2017 revenue $10 million.Q2 loss per share $0.06.Biolife Solutions Inc says reaffirms full-year revenue guidance for biopreservation media products.  Full Article

BioLife Solutions executes supply agreement with Celyad for CryoStor
Monday, 31 Jul 2017 06:30am EDT 

July 31 (Reuters) - BioLife Solutions Inc :Biolife Solutions executes supply agreement with Celyad for CryoStor use in natural killer receptor based t-cell (nkr-t) platform targeting solid tumors and blood cancers.Biolife Solutions Inc - has executed a long term supply agreement with Celyad.Biolife Solutions Inc - co's CryoStor clinical grade cell freeze media is incorporated into Celyad's manufacturing process.  Full Article

Biolife Solutions modifies existing credit facility
Wednesday, 5 Jul 2017 06:00am EDT 

July 5 (Reuters) - Biolife Solutions Inc ::Biolife Solutions modifies existing credit facility.Biolife Solutions Inc - has reached an agreement with wavi holding to modify its existing credit facility effective June 30, 2017.Biolife Solutions - Wavi agreed to exchange $4.25 million credit facility for 4,250 shares of series a preferred stock​.Biolife Solutions Inc - no additional consideration was provided to Wavi for entering into agreement.Biolife Solutions-preferred shares carry annual cash dividend of 10 pct of outstanding stated value, calculated and payable in arrears on quarterly basis.  Full Article

Biolife Solutions executes supply agreement with Adaptimmune for Cryostor
Wednesday, 14 Jun 2017 06:00am EDT 

June 14 (Reuters) - Biolife Solutions Inc :Biolife solutions executes supply agreement with adaptimmune for cryostor® use in spear t-cell platform.Biolife solutions inc - that it has entered into a supply agreement with nasdaq-listed adaptimmune therapeutics plc.  Full Article

Biolife Solutions reports Q1 loss per share $0.07
Thursday, 11 May 2017 04:05pm EDT 

May 11 (Reuters) - Biolife Solutions Inc :Biolife Solutions announces Q1 2017 financial results.Biolife Solutions Inc - qtrly product revenue $2.4 million versus $1.9 million; qtrly loss per share $0.07.Biolife Solutions Inc - management reaffirms full-year 2017 guidance provided in January.Q1 earnings per share view $-0.05, revenue view $2.3 million -- Thomson Reuters I/B/E/S.FY2017 earnings per share view $-0.16, revenue view $10.5 million -- Thomson Reuters I/B/E/S.  Full Article

Biolife Solutions posts 4th quarter, full year 2016 results
Thursday, 9 Mar 2017 04:05pm EST 

Biolife Solutions Inc : Biolife solutions reports 4th quarter and full year 2016 results . Biolife solutions inc - management reaffirms full-year 2017 guidance provided in january . Biolife solutions inc - consolidated operating loss for q4 was $0.6 million compared to $1.1 million in q3 2016 .Biolife solutions inc - revenue from biopreservation media product sales of $2.3 million in q4 of 2016, an increase of 24% over same period in 2015.  Full Article

Biolife Solutions says expects $1.6 mln-$2mln annual expense reduction from Biologistex JV restructuring - SEC filing
Thursday, 16 Feb 2017 09:31am EST 

Biolife Solutions Inc :Biolife Solutions Inc - anticipate $1.6 mln-$2mln annual expense reduction from Biologistex JV restructuring - SEC filing.  Full Article

Biolife Solutions announces 2016 revenue growth of 28 pct
Thursday, 12 Jan 2017 06:00am EST 

Biolife Solutions Inc : Biolife solutions announces 2016 revenue growth of 28 pct . Biolife solutions sees 2017 biopreservation media revenue growth of 20-25 pct over 2016; revenue in excess of $10 million . Sees 2017 gross margin, as a percent of sales, between 55 pct to 60 pct . Sees 2017 biopreservation media revenue growth of 20-25 pct over 2016 . Sees 2017 revenue in excess of $10 million .FY2017 revenue view $11.3 million -- Thomson Reuters I/B/E/S.  Full Article